BioCorRx Inc
OTC:BICX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.204
0.525
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
BioCorRx Inc
OTC:BICX
|
9.5m USD |
Loading...
|
|
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
107B USD |
Loading...
|
|
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR |
Loading...
|
|
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
75.8B MYR |
Loading...
|
|
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
95.8B BRL |
Loading...
|
|
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.5B USD |
Loading...
|
|
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
105.4B CNY |
Loading...
|
|
| US |
|
Universal Health Services Inc
NYSE:UHS
|
12.8B USD |
Loading...
|
|
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
201.9T IDR |
Loading...
|
|
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
978.2B INR |
Loading...
|
|
| IN |
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
963.9B INR |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
BioCorRx Inc
Glance View
BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. The company is headquartered in Anaheim, California. The company went IPO on 2010-08-31. The firm's BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The company is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX104. Its lead candidate, BICX101, is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. The company is also developing an implantable naltrexone treatment, BICX104, a long-acting naltrexone implant that can last several months for the treatment of opioid dependence and alcohol use disorders. Its subsidiary is BioCorRx Pharmaceuticals, Inc.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for BioCorRx Inc is -1 640.5%, which is above its 3-year median of -11 021%.
Over the last 3 years, BioCorRx Inc’s Operating Margin has increased from -9 066.7% to -1 640.5%. During this period, it reached a low of -66 526% on Dec 31, 2024 and a high of -1 640.5% on Jul 30, 2025.